Peritoneal Dialysis Schedules for Kidney Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to compare days-off (5 or 6 days a week) with daily (7 days a week) peritoneal dialysis (PD) in adults who are starting PD to treat kidney failure and make at least 16 ounces (two cups) of urine a day. Once enrolled, participants will be placed into one of two groups by chance, like flipping a coin: days-off PD or daily PD. Participants will be asked to stay on the assigned PD schedule (days-off or daily) for at least 6 months. After that, participants will continue this schedule for as long as it continues to be right for their health. Participants will be followed for as long as they remain on PD, up to 24 months. Most participants assigned to the days-off schedule will switch to daily PD at some point between 6 and 24 months because of further drop in urine output. Other than days per week, all parts of participant's PD prescription will be decided by their care team at their regular monthly PD clinic visits, just as if they were not in the study. Study visits will happen around the time of these regular clinic visits. No extra trips are required. Participants will be asked to complete surveys. Most other study data will be collected from the medical chart. No blood or biological samples will be taken for the study.
Who Is on the Research Team?
Bruce Robinson, MD, MS
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for adults with kidney failure who are starting peritoneal dialysis and still make at least two cups (16 ounces) of urine a day. Participants must be able to follow the assigned dialysis schedule.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two ways of doing peritoneal dialysis: every day (7 days a week) versus taking one or two days off each week (5-6 days). Participants are randomly assigned to either group and followed for up to 24 months.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Approximately 225 participants
Approximately 225 participants
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.